Literature DB >> 16196102

Pigment epithelium-derived factor is differentially expressed in peripheral neuropathies.

Antonio Conti1, Piero Ricchiuto, Sandro Iannaccone, Barbara Sferrazza, Angela Cattaneo, Angela Bachi, Angelo Reggiani, Massimiliano Beltramo, Massimo Alessio.   

Abstract

Peripheral neuropathies are characterized by asymmetrical slowly progressive weakness with no upper motor neuron signs, and can occur either with or without pain. Due to poor knowledge of the disease mechanisms, available pain treatment is very limited. Because of the difficulties and invasiveness involved when performing direct analysis on peripheral and CNS, pathological markers can be searched for in the cerebrospinal fluid (CSF) as an alternative. To investigate pain mechanisms in peripheral neuropathy and find diagnostic markers, CSF samples were analyzed by a differential expression proteomic approach. We studied CSF from: neuropathic patients with pain (PN), without pain (NPN) and healthy controls (CN). 2-DE analysis showed ten protein spots differentially expressed, and six of these were identified by MS. In NPN patients we found an expression level decrease of three pigment epithelium-derived factor (PEDF) protein isoforms. Immunoblot with a specific antibody revealed the presence of additional PEDF isoforms not highlighted by differential expression analysis. Fucose residues on the oligosaccharide chain were found only in the isoforms down regulated in NPN patients. Considered as PEDF has important neurobiological effects, it might be considered an interesting pathology marker.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16196102     DOI: 10.1002/pmic.200402088

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  13 in total

1.  Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines.

Authors:  Maria S Pino; Michele Balsamo; Francesca Di Modugno; Marcella Mottolese; Massimo Alessio; Elisa Melucci; Michele Milella; David J McConkey; Ulrike Philippar; Frank B Gertler; Pier Giorgio Natali; Paola Nisticò
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

2.  Evidence for a Role of Nerve Injury in Painful Intervertebral Disc Degeneration: A Cross-Sectional Proteomic Analysis of Human Cerebrospinal Fluid.

Authors:  Tony K Y Lim; Kathleen M Anderson; Pawan Hari; Marcos Di Falco; Troy E Reihsen; George L Wilcox; Kumar G Belani; Sylvie LaBoissiere; Manuel R Pinto; David S Beebe; Lois J Kehl; Laura S Stone
Journal:  J Pain       Date:  2017-06-24       Impact factor: 5.820

3.  Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.

Authors:  Francesca Di Modugno; Lucia DeMonte; Michele Balsamo; Giovanna Bronzi; Maria Rita Nicotra; Massimo Alessio; Elke Jager; John S Condeelis; Angela Santoni; Pier Giorgio Natali; Paola Nisticò
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

4.  The cooperation between hMena overexpression and HER2 signalling in breast cancer.

Authors:  Francesca Di Modugno; Marcella Mottolese; Lucia DeMonte; Paola Trono; Michele Balsamo; Andrea Conidi; Elisa Melucci; Irene Terrenato; Francesca Belleudi; Maria Rosaria Torrisi; Massimo Alessio; Angela Santoni; Paola Nisticò
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

5.  Nonlinear dimension reduction and clustering by Minimum Curvilinearity unfold neuropathic pain and tissue embryological classes.

Authors:  Carlo Vittorio Cannistraci; Timothy Ravasi; Franco Maria Montevecchi; Trey Ideker; Massimo Alessio
Journal:  Bioinformatics       Date:  2010-09-15       Impact factor: 6.937

6.  Identification of pigment epithelium-derived factor protein forms with distinct activities on tumor cell lines.

Authors:  P Subramanian; M Deshpande; S Locatelli-Hoops; S Moghaddam-Taaheri; D Gutierrez; D P Fitzgerald; S Guerrier; M Rapp; V Notario; S P Becerra
Journal:  J Biomed Biotechnol       Date:  2012-06-04

Review 7.  PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases.

Authors:  Xuemin He; Rui Cheng; Siribhinya Benyajati; Jian-xing Ma
Journal:  Clin Sci (Lond)       Date:  2015-06       Impact factor: 6.124

8.  Multivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls - a hypothesis-generating pilot study.

Authors:  Emmanuel Bäckryd; Bijar Ghafouri; Anders K Carlsson; Patrik Olausson; Björn Gerdle
Journal:  J Pain Res       Date:  2015-07-01       Impact factor: 3.133

9.  Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.

Authors:  Alan Zanardi; Antonio Conti; Marco Cremonesi; Patrizia D'Adamo; Enrica Gilberti; Pietro Apostoli; Carlo Vittorio Cannistraci; Alberto Piperno; Samuel David; Massimo Alessio
Journal:  EMBO Mol Med       Date:  2018-01       Impact factor: 12.137

10.  Specific proteins of the trapezius muscle correlate with pain intensity and sensitivity - an explorative multivariate proteomic study of the trapezius muscle in women with chronic widespread pain.

Authors:  Patrik Olausson; Bijar Ghafouri; Nazdar Ghafouri; Björn Gerdle
Journal:  J Pain Res       Date:  2016-06-02       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.